We are live on ! Find out more
INM icon

InMed Pharmaceuticals
INM

9 hedge funds and large institutions have $665K invested in InMed Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,234% more capital invested

Capital invested by funds: $28.5K → $665K (+$637K)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

29% more funds holding

Funds holding: 7 → 9 (+2)

14.46% more ownership

Funds ownership: 0.7% → 15.16% (+14%)

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
Sabby Management
Florida
+$530K
2
DS
DRW Securities
Illinois
+$86.5K
3
VF
Virtu Financial
New York
+$49.1K
4
Renaissance Technologies
Renaissance Technologies
New York
+$40.5K
5
TDC
Thompson Davis & Co
Virginia
+$24.7K

Top Sellers

1
UBS Group
UBS Group
Switzerland
-$25.2K
2
TRCT
Tower Research Capital (TRC)
New York
-$1.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$482K +$530K +219,998 New
DS
2
DRW Securities
Illinois
$78.5K +$86.5K +35,865 New
VF
3
Virtu Financial
New York
$45K +$49.1K +20,369 New
Renaissance Technologies
4
Renaissance Technologies
New York
$36.8K +$40.5K +16,800 New
TDC
5
Thompson Davis & Co
Virginia
$22.4K +$24.7K +10,249 New
SS
6
SBI Securities
Japan
$657 – – –
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4 +$2 +1 +100%
AWM
8
AllSquare Wealth Management
New York
$2 – – –
UBS Group
9
UBS Group
Switzerland
– -$25.2K -7,762 Closed
TRCT
10
Tower Research Capital (TRC)
New York
– -$1.3K -400 Closed